Sugi Predict

Sugi Predict / Compounds / SCHEMBL1010756

SCHEMBL1010756

SCHEMBL1010756

CC(=O)OP(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ HSD17B10 Q99714 3/20 0.39
▸ TSHR P16473 3/20 0.39
▸ ESR1 P03372 3/20 0.39
▸ NAPRT Q6XQN6 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ELANE P08246 1/20 0.39
▸ ITGB3 P05106 1/20 0.39
▸ ITGA2B P08514 1/20 0.39
▸ HMGB1 P09429 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ GGT1 P19440 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13372616 0.98 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL10527995 0.98 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL27261674 0.98 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL28561030 0.79 ELANE (0.45) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL8511954 0.79 CA12 (0.42) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL27462641 0.78 MGAM (0.40) ALDH1A1HSD17B10TSHRNAPRTKDM4E
SCHEMBL28415477 0.77 ALDH1A1 (0.38) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL1095112 0.77 ELANE (0.43) ALDH1A1TSHRESR1KDM4EELANE
SCHEMBL22801166 0.77 MEN1 (0.32) ALDH1A1HSD17B10TSHRESR1NAPRT
SCHEMBL2321740 0.76 LMNA (0.54) ALDH1A1HSD17B10TSHRNAPRTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180831-B1 REACTING 1,2-OXIRANES WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF COBALT TRANSITION METAL COMPOUND CATALYST, WHEREIN SAID COBALT TRANSITION METAL COMPOUND IS MODIFIED WITH PHOSPHORUS-OXYGEN LIGAND OR NITROGEN-OXYGEN LIGAND DEGUSSA-HULS AG (DE) 2001-01-30 — — US claimed
CN-108884010-B Process for preparing unsaturated carboxylic acid salts 巴斯夫欧洲公司 2022-11-08 — — CN disclosed
CN-115298157-A Catalytic process for preparing alpha, beta-ethylenically unsaturated carboxylic acid salts 巴斯夫欧洲公司 2022-11-04 — — CN disclosed
CN-107580593-B Process for preparing unsaturated carboxylic acid salts 巴斯夫欧洲公司 2021-03-02 — — CN disclosed
CN-106458824-B Method for preparing unsaturated carboxylic acid salt using aryl oxide 巴斯夫欧洲公司 2020-10-16 — — CN disclosed
CN-111032609-A High porosity aromatic resins as promoters in the production of acrylates by coupling reactions of olefins and carbon dioxide 切弗朗菲利浦化学公司 2020-04-17 — — CN disclosed
CN-106604957-B Plasticizer composition comprising polymerizeing dicarboxylic ester 巴斯夫欧洲公司 2019-11-05 — — CN disclosed
CN-107428990-B Plasticizer composition comprising polymerization dicarboxylic ester and dimethyl terephthalate ester 巴斯夫欧洲公司 2019-07-12 — — CN disclosed
US-10308563-B2 Process for producing ethylene oligomers HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) 2019-06-04 — — US disclosed
CN-106232571-B The method of carboxylate and its purposes as plasticiser are prepared in the presence of ionic liquid and acid esterification catalyst 巴斯夫欧洲公司 2019-05-28 — — CN disclosed
US-20100190984-A1 Light emitting material SOLVAY (SOCIETE ANONYME) (BE) 2010-07-29 — — US disclosed
EP-2155764-A1 LIGHT EMITTING MATERIAL SOLVAY (Société Anonyme) (BE) 2010-02-24 — — EP disclosed
WO-2008148829-A1 LIGHT EMITTING MATERIAL Solvay (Société Anonyme) (BE) 2008-12-11 — — WO disclosed
US-20050070425-A1 Catalytic composition and process for the selective oligomerization of ethylene to light linear alpha-olefins POLIMERI EUROPA S.P.A (IT) 2005-03-31 — — US disclosed
EP-1453604-A2 CATALYTIC COMPOSITION AND PROCESS FOR THE SELECTIVE OLIGOMERIZATION OF ETHYLENE TO LIGHT LINEAR ALPHA-OLEFINS Polimeri Europa S.r.l. (IT) 2004-09-08 — — EP disclosed
WO-2003053573-A2 CATALYTIC COMPOSITION AND PROCESS FOR THE SELECTIVE OLIGOMERIZATION OF ETHYLENE TO LIGHT LINEAR ALPHA-OLEFINS POLIMERI EUROPA S.P.A. (IT) 2003-07-03 — — WO disclosed
US-6180831-B1 REACTING 1,2-OXIRANES WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF COBALT TRANSITION METAL COMPOUND CATALYST, WHEREIN SAID COBALT TRANSITION METAL COMPOUND IS MODIFIED WITH PHOSPHORUS-OXYGEN LIGAND OR NITROGEN-OXYGEN LIGAND DEGUSSA-HULS AG (DE) 2001-01-30 — — US disclosed
EP-0082576-B1 A PROCESS FOR THE HYDROFORMYLATION OF OLEFINS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-02-20 — — EP disclosed
US-4408078-A Process for the hydroformylation of olefins SHELL OIL COMPANY (US) 1983-10-04 — — US disclosed
EP-0082576-A1 A process for the hydroformylation of olefins SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-06-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190984-A1 Light emitting material PPOX, CRY2, PIN4 ALDH1A1 3043/4885HSD17B10 4863/4885TSHR 4486/4885
US-10308563-B2 Process for producing ethylene oligomers OXER1, HAO2, ORC3 ALDH1A1 1507/4885HSD17B10 267/4885TSHR 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.